Key statistics
On Thursday, LSL Pharma Group Inc (LSL:CVE) closed at 0.435, 24.29% above the 52 week low of 0.35 set on Feb 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.46 |
---|---|
High | 0.46 |
Low | 0.43 |
Bid | 0.435 |
Offer | 0.44 |
Previous close | 0.435 |
Average volume | 63.29k |
---|---|
Shares outstanding | 115.53m |
Free float | 82.91m |
P/E (TTM) | -- |
Market cap | 50.26m CAD |
EPS (TTM) | -0.0232 CAD |
Data delayed at least 15 minutes, as of Nov 14 2024 20:00 GMT.
More ▼
- LSL PHARMA GROUP ANNONCES $1.4 MILLION OF NEW ORDERS FROM INTERNATIONAL CLIENTS AND COMPLETION OF STERI-MED PHARMA'S PHASE 1 PRODUCTION SCALE UP
- LSL PHARMA GROUP ANNOUNCES THE FIRST INTEREST PAYMENT ON THE CONVERTIBLE DEBENTURES LISTED AS LSL.DB
- LSL PHARMA GROUP ANNOUNCES CHANGE OF AUDITORS AND GRANT OF OPTIONS
- LSL PHARMA GROUP REPORTS RECORD REVENUES FOR THE SECOND QUARTER 2024